Dr. Kulkarni most recently served as Chief Scientific Officer and Senior Vice President of Innovation and Emerging Business at Baylor Genetics. At Baylor, he led an extensive clinical and translational research team, delivering top-quality clinical genomics and multi-omics tools.
Dr. Kulkarni is considered a world-renowned expert and key opinion leader in cancer genomics with a focus on applying genomic and multi-omic technologies to improve the understanding of human disease and the precision of clinical diagnosis, prognosis, and treatment. He has given numerous national and international presentations and, as a leading voice, presented his insight, thoughts, and opinions as a frequent guest on multiple major news outlets across the country. Additionally, he has published extensively in peer-reviewed articles and numerous well-known journals. He is the Editor-in-Chief of Cancer Genetics Journal and has co-edited a book, available on Amazon, titled Clinical Genomics – A Guide to Clinical Next-Generation Sequencing.